Johnson & Johnson Sues Barr Laboraties Over Contraceptive
Barr applied to the Food and Drug Administration in June to sell a generic version of the contraceptive. The pill, with $110 million in sales per year, was introduced in September 2002.
The suit automatically blocks the F.D.A. from granting final approval for...
To view the full article, register now.